<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00597467</url>
  </required_header>
  <id_info>
    <org_study_id>CVI060105</org_study_id>
    <nct_id>NCT00597467</nct_id>
  </id_info>
  <brief_title>Study of Soft Contact Lens Use With 7 Day Extended Wear</brief_title>
  <official_title>An Open-Labeled, Multi-Center, Randomized Investigation of the VISA (Comfilcon A) Silicone Hydrogel Soft (Hydrophilic) Contact Lens for Use in a 7 Day Extended Wear Regimen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the safety and efficacy of the CVI silicone-hydrogel lens worn on an extended wear
      basis for a period of up to 7 days and 6 nights with the Acuvue 2 soft contact lenses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare the safety and efficacy of the CVI silicone-hydrogel lens worn on an extended wear
      basis for a period of up to 7 days and 6 nights with the Acuvue 2 soft contact lenses in this
      open-labeled randomized study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of serious and significant AEs</measure>
    <time_frame>1 Year</time_frame>
    <description>Frequency of serious and significant AEs defined as a composite of infiltrates of higher than grade 2 and/or infiltrates with any overlying staining, peripheral ulcer, and loss of two or more lines of visual acuity at any time during the trial</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Contact Lens Visual Acuity</measure>
    <time_frame>1 Year</time_frame>
    <description>Contact lens visual acuity was assessed using LogMAR</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">460</enrollment>
  <condition>Ametropia</condition>
  <arm_group>
    <arm_group_label>Test Contact Lenses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VISA (comfilcon A) Silicone Hydrogel Soft contact lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Contact Lenses</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acuvue 2 Soft Contact Lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VISA (comfilcon A) Silicone Hydrogel Soft contact lens</intervention_name>
    <description>Test device</description>
    <arm_group_label>Test Contact Lenses</arm_group_label>
    <other_name>Biofinity (comfilcon A)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acuvue 2 Soft Contact Lens</intervention_name>
    <description>Control device</description>
    <arm_group_label>Control Contact Lenses</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Be at least 18 years of age as of the date of evaluation.

          2. Require lens powers between -0.50 and -6.00 diopters sphere with no more than 1.00
             diopter of refractive astigmatism and be willing to wear lenses in both eyes.

          3. Be correctable to visual acuities of at least 20/25 in each eye with spectacles.

          4. Be in good general health, based on his/her knowledge.

          5. Be able and willing to adhere to the instructions set forth in this protocol and able
             to keep all specified appointments.

          6. Possess wearable and visually functional eyeglasses.

        Exclusion Criteria:

          1. Previously unsuccessful with contact lens wear.

          2. Rigid gas permeable contact lens wear within the past 12 months.

          3. Previous refractive surgery; current or previous orthokeratology treatment.

          4. Subject is wearing lenses in a modified monovision modality (multifocal lens in one
             eye). NOTE: subjects may not wear monovision lenses at any time during the study
             unless they are wearing spherical monovision lenses prior to enrollment.

          5. Aphakia, keratoconus or an irregular cornea.

          6. A known history of corneal hypoesthesia

          7. Clinically significant (grade 3 or 4) anterior segment abnormalities or any infection
             of the eye, lids, or associated structures.

          8. Ocular or systemic disease or need for medication which might interfere with contact
             lens wear. i.e., Sjögren's syndrome, type II diabetes, etc.

          9. Slit lamp findings that would contraindicate contact lens wear, including but not
             limited to:

               -  History of corneal ulcer, corneal infiltrates or fungal infections.

               -  Pterygium, pinguecula or corneal scars within the visual axis

               -  Pathological dry eye or associated findings (examples: Sjögren's syndrome, lupus
                  erythematosus, sclerodermia)

               -  Neovascularization or ghost vessels &gt; 1mm in from the limbus

               -  Seborrheic eczema, seborrheic conjunctivitis

               -  History of papillary conjunctivitis greater than Grade 2 (Mild)

               -  Anterior uveitis or iritis (past or present)

         10. Known sensitivity to the care systems used in this study.

         11. Poor personal hygiene

         12. Current pregnancy or is lactating (to the best of the subject's knowledge) or subject
             is planning pregnancy within the next 13 months.

         13. Any active participation in another clinical study within 30 days prior to this study.

         14. Subject is a member, relative or household member of the office staff, including the
             investigator(s).

        Subjects must read, indicate understanding of, and sign the Informed Consent Form.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William Gleason, OD</last_name>
    <role>Study Director</role>
    <affiliation>FRS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>La Mesa Vision Care Center</name>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91941</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>(Private Practice)</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Drs. Cook, Reeder and Associates</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92129</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>(Private Practice)</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Care Associates, P.C.</name>
      <address>
        <city>Fort Collins</city>
        <state>Colorado</state>
        <zip>80521</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eola Eyes</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>(Private Practice)</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96814</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kato &amp; Shoji Optometrists</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Care Associates of Hawaii</name>
      <address>
        <city>Waipahu</city>
        <state>Hawaii</state>
        <zip>96797</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Davis Eyecare Associates</name>
      <address>
        <city>Oak Lawn</city>
        <state>Illinois</state>
        <zip>60453</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>(Private Practice)</name>
      <address>
        <city>Andover</city>
        <state>Massachusetts</state>
        <zip>01810</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vision Care Associates</name>
      <address>
        <city>East Lansing</city>
        <state>Michigan</state>
        <zip>48823</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Koetting Associates Inc.</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Concord Ophthalmological Associates</name>
      <address>
        <city>Concord</city>
        <state>New Hampshire</state>
        <zip>03301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Place Optical Company Inc</name>
      <address>
        <city>Le Roy</city>
        <state>New York</state>
        <zip>14482</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Quinn Quinn &amp; Associates</name>
      <address>
        <city>Athens</city>
        <state>Ohio</state>
        <zip>45701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western Reserve Vision Care</name>
      <address>
        <city>Beachwood</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Professional Eye Care Associates</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Primary Eyecare Group, P.C.</name>
      <address>
        <city>Brentwood</city>
        <state>Tennessee</state>
        <zip>37027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>(Private Practice)</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Twin Lakes Vision</name>
      <address>
        <city>Federal Way</city>
        <state>Washington</state>
        <zip>98023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Snowy Range Vision Center</name>
      <address>
        <city>Laramie</city>
        <state>Wyoming</state>
        <zip>82070</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 27, 2007</study_first_submitted>
  <study_first_submitted_qc>January 9, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 18, 2008</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>myopia</keyword>
  <keyword>hyperopia</keyword>
  <keyword>extended wear</keyword>
  <keyword>ametropia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

